Biomerica Inc.

BMRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.60

+$0.09 (+3.59%)

At close: Sep 21, 2026, 4:00 PM ET

$2.54

-$0.06 (-2.31%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.59%

(1D)

Rating

Updated: Aug 27, 2026

20.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $8.03M

1D Range

2.48 2.60

52W Range

1.45 3.21

Valuation (TTM)

PE -2.06

PB 3.06

EV/EBITDA -2.31

Valuation (NTM)

Forward PE N/A

Forward PEG 0.34

Price Target N/A

Cash Flow

FCF Yield -43.0%

SBC Adj. FCF Yield -53.0%

SBC Impact -23.2%

Margins

Gross Margin 8.1%

Operating Margin -119.5%

FCF Margin -77.7%

Growth (CAGR)

Revenue 3Y | 5Y -5.9% | -9.2%

Dil EPS 3Y | 5Y -69.3% | -29.1%

FCF 3Y | 5Y 23.7% | -10.3%

Returns

ROA -55.9%

ROE -97.2%

ROIC -117.9%

Financial Health

Net Debt

$575K

Current Ratio 1.62

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addres...

Sector Healthcare

Industry Medical - Devices

Employees 54

IPO Date Sep 6, 1984

Website www.biomerica.com

Fiscal Year June - May

Full Company Profile

Latest News

No news articles available yet.

Earnings

Latest Earnings

Aug 31, 2026

EPS

-$0.38

Beat +68.33%

YoY: -137.50%

REV

$875K

Miss -75.89%

YoY: +16.82%

Next Earnings

Oct 21, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞